Completed
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
NCT01189383
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- Baylor University Medical Center Dallas, Texas, United States